Edge Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$37K Hold
351
﹤0.01% 555
2018
Q1
$37K Hold
351
﹤0.01% 564
2017
Q4
$40K Buy
351
+123
+54% +$13.9K ﹤0.01% 553
2017
Q3
$25K Hold
228
﹤0.01% 626
2017
Q2
$27K Sell
228
-309
-58% -$36.6K ﹤0.01% 614
2017
Q1
$63K Buy
537
+298
+125% +$33.8K 0.01% 471
2016
Q4
$23K Buy
+239
New +$25.6K ﹤0.01% 606

Other funds holding ZBH

Edge Advisors's ZBH Position: Q2 2018 in Review

Edge Advisors held its Zimmer Biomet (ZBH) position steady in Q2 2018 at 351 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Edge Advisors first reported a position in ZBH in Q4 2016 and has held it in 7 quarters since. The position peaked at $63K in Q1 2017. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

  • Edge Advisors held 351 shares of Zimmer Biomet worth $37K as of Q2 2018.
  • Edge Advisors left its Zimmer Biomet share count unchanged in Q2 2018.
  • Zimmer Biomet made up ﹤0.01% of Edge Advisors's portfolio in Q2 2018, its #555 holding.
  • Edge Advisors first reported a position in Zimmer Biomet in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Zimmer Biomet position peaked at $63K in Q1 2017.
  • 869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.